Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 9Recruiting 4Active not recruiting 3Withdrawn 2Unknown 2Terminated 1Suspended 1Not yet recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1

Interventions

tivozanib 1pegamotecan 1envafolimab 1atezolizumab 1Vincristine 1Vaccines 1Temozolomide 1Nanoparticles 1Health Care Economics and Organizations 1HMPL-013 1Biomarkers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Sarcoma × Temozolomide × Clear all
NCT04890093 2026-03-16

Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1/2 Suspended
64 enrolled
Sarcoma

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡